UBS Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.92M | Sell |
|
|||||
|
2025
Q2 | $2.47M | Sell |
|
|||||
|
2025
Q1 | $2.7M | Buy |
|
|||||
|
2024
Q4 | $2.72M | Buy |
|
|||||
|
2024
Q3 | $1.09M | Sell |
|
|||||
|
2024
Q2 | $1.14M | Buy |
|
|||||
|
2024
Q1 | $2.54M | Buy |
|
|||||
|
2023
Q4 | $333K | Buy |
|
|||||
|
2023
Q3 | $189K | Sell |
|
|||||
|
2023
Q2 | $3.06M | Buy |
|
|||||
|
2023
Q1 | $424K | Sell |
|
|||||
|
2022
Q4 | $432K | Sell |
|
|||||
|
2022
Q3 | $465K | Buy |
|
|||||
|
2022
Q2 | $175K | Sell |
|
|||||
|
2022
Q1 | $885K | Sell |
|
|||||
|
2021
Q4 | $2.05M | Sell |
|
|||||
|
2021
Q3 | $2.8M | Sell |
|
|||||
|
2021
Q2 | $5.43M | Buy |
|
|||||
|
2021
Q1 | $2.89M | Buy |
|
|||||
|
2020
Q4 | $2.15M | Buy |
|
|||||
|
2020
Q3 | $373K | Buy |
|
|||||
|
2020
Q2 | $119K | Sell |
|
|||||
|
2020
Q1 | $451K | Sell |
|
|||||
|
2019
Q4 | $5.97M | Sell |
|
|||||
|
2019
Q3 | $8.18M | Sell |
|
|||||
|
2019
Q2 | $9.98M | Buy |
|
|||||
|
2019
Q1 | $11.2M | Sell |
|
|||||
|
2018
Q4 | $14.2M | Buy |
|
|||||
|
2018
Q3 | $2.66M | Buy |
|
|||||
|
2018
Q2 | $1.39M | Buy |
|
|||||
|
2018
Q1 | $619K | Buy |
|
|||||
|
2017
Q4 | $461K | Sell |
|
|||||
|
2017
Q3 | $1.45M | Buy |
|
|||||
|
2017
Q2 | $403K | Sell |
|
|||||
|
2017
Q1 | $586K | Sell |
|
|||||
|
2016
Q4 | $22.1M | Buy |
|
|||||
|
2016
Q3 | $724K | Sell |
|
|||||
|
2016
Q2 | $798K | Buy |
|
|||||
|
2016
Q1 | $64K | Sell |
|
|||||
|
2015
Q4 | $128K | Buy |
|
|||||
|
2015
Q3 | $22K | Sell |
|
|||||
|
2015
Q2 | $53K | Buy |
|
|||||
|
2015
Q1 | $19K | Buy |
|
|||||
|
2014
Q4 | $20K | Buy |
|